Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications.

Garcia A, Mack P, Williams S, Fromen C, Shen T, Tully J, Pillai J, Kuehl P, Napier M, Desimone JM, Maynor BW.

J Drug Deliv. 2012;2012:941243. doi: 10.1155/2012/941243. Epub 2012 Feb 9.

PMID:
22518316
[PubMed]
Free PMC Article
2.

Future of the particle replication in nonwetting templates (PRINT) technology.

Xu J, Wong DH, Byrne JD, Chen K, Bowerman C, DeSimone JM.

Angew Chem Int Ed Engl. 2013 Jun 24;52(26):6580-9. doi: 10.1002/anie.201209145. Epub 2013 May 13. Review.

PMID:
23670869
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.

Sheth P, Sandhu H, Singhal D, Malick W, Shah N, Kislalioglu MS.

Curr Drug Deliv. 2012 May;9(3):269-84. Review.

PMID:
22283656
[PubMed - indexed for MEDLINE]
4.

Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.

Gratton SE, Pohlhaus PD, Lee J, Guo J, Cho MJ, Desimone JM.

J Control Release. 2007 Aug 16;121(1-2):10-8. Epub 2007 Jun 2.

PMID:
17643544
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The role of particle properties in pharmaceutical powder inhalation formulations.

Chew NY, Chan HK.

J Aerosol Med. 2002 Fall;15(3):325-30. Review.

PMID:
12396421
[PubMed - indexed for MEDLINE]
6.

Dry powder aerosol delivery systems: current and future research directions.

Chan HK.

J Aerosol Med. 2006 Spring;19(1):21-7. Review.

PMID:
16551211
[PubMed - indexed for MEDLINE]
7.

Formulation strategy and use of excipients in pulmonary drug delivery.

Pilcer G, Amighi K.

Int J Pharm. 2010 Jun 15;392(1-2):1-19. doi: 10.1016/j.ijpharm.2010.03.017. Epub 2010 Mar 17. Review.

PMID:
20223286
[PubMed - indexed for MEDLINE]
8.

Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology.

Cheng YS, Yazzie D, Gao J, Muggli D, Etter J, Rosenthal GJ.

J Aerosol Med. 2003 Spring;16(1):65-73.

PMID:
12737686
[PubMed - indexed for MEDLINE]
9.

Development of dry powder inhalers.

Chougule MB, Padhi BK, Jinturkar KA, Misra A.

Recent Pat Drug Deliv Formul. 2007;1(1):11-21. Review.

PMID:
19075871
[PubMed - indexed for MEDLINE]
10.

Development of budesonide nanocluster dry powder aerosols: processing.

El-Gendy N, Selvam P, Soni P, Berkland C.

J Pharm Sci. 2012 Sep;101(9):3425-33. doi: 10.1002/jps.23168. Epub 2012 Apr 26.

PMID:
22539360
[PubMed - indexed for MEDLINE]
11.

Crystallization of progesterone for pulmonary drug delivery.

Ragab D, Rohani S, Samaha MW, El-Khawas FM, El-Maradny HA.

J Pharm Sci. 2010 Mar;99(3):1123-37. doi: 10.1002/jps.21896.

PMID:
19691108
[PubMed - indexed for MEDLINE]
12.

Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.

Crowder TM, Rosati JA, Schroeter JD, Hickey AJ, Martonen TB.

Pharm Res. 2002 Mar;19(3):239-45. Review.

PMID:
11934228
[PubMed - indexed for MEDLINE]
13.

Pharmaceutical spray drying: solid-dose process technology platform for the 21st century.

Snyder HE.

Ther Deliv. 2012 Jul;3(7):901-12.

PMID:
22900470
[PubMed - indexed for MEDLINE]
14.

Effervescent dry powder for respiratory drug delivery.

Ely L, Roa W, Finlay WH, Löbenberg R.

Eur J Pharm Biopharm. 2007 Mar;65(3):346-53. Epub 2006 Nov 7.

PMID:
17156987
[PubMed - indexed for MEDLINE]
15.

Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery.

Zeng XM, Martin GP, Marriott C, Pritchard J.

J Pharm Sci. 2001 Sep;90(9):1424-34.

PMID:
11745794
[PubMed - indexed for MEDLINE]
16.

Formulation and evaluation of insulin dry powder for inhalation.

Mahesh Kumar T, Misra A.

Drug Dev Ind Pharm. 2006 Jul;32(6):677-86.

PMID:
16885123
[PubMed - indexed for MEDLINE]
17.

Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.

Lucas P, Anderson K, Staniforth JN.

Pharm Res. 1998 Apr;15(4):562-9.

PMID:
9587952
[PubMed - indexed for MEDLINE]
18.

EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin.

White S, Bennett DB, Cheu S, Conley PW, Guzek DB, Gray S, Howard J, Malcolmson R, Parker JM, Roberts P, Sadrzadeh N, Schumacher JD, Seshadri S, Sluggett GW, Stevenson CL, Harper NJ.

Diabetes Technol Ther. 2005 Dec;7(6):896-906.

PMID:
16386095
[PubMed - indexed for MEDLINE]
19.

Nanoparticles for drug delivery to the lungs.

Sung JC, Pulliam BL, Edwards DA.

Trends Biotechnol. 2007 Dec;25(12):563-70. Epub 2007 Nov 8. Review.

PMID:
17997181
[PubMed - indexed for MEDLINE]
20.

Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies.

Kaye RS, Purewal TS, Alpar HO.

J Pharm Sci. 2009 Nov;98(11):4055-68. doi: 10.1002/jps.21673.

PMID:
19189420
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk